PRECIGEN, INC. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
PRECIGEN, INC. (PGEN) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 83.83 million shares for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-04
- PRECIGEN, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 83.83M shares, a 3.51% increase year-over-year.
- PRECIGEN, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 80.99M shares, a 244.62% increase year-over-year.
- PRECIGEN, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2024-03-31 was 23.50M shares, a 24.86% increase year-over-year.
- PRECIGEN, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2023-03-31 was 18.82M shares, a 8.54% increase year-over-year.
- PRECIGEN, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 84.19M shares, a 1.93% increase from fiscal 2024.
- PRECIGEN, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 82.60M shares, a 258.82% increase from fiscal 2023.
- PRECIGEN, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 23.02M shares, a 44.78% increase from fiscal 2022.
- PRECIGEN, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 15.90M shares, a 23.72% increase from fiscal 2021.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 83.83M shares 10-Q · filed 2026-05-13 | |||||||
| 2025-12-31 | 84.19M shares 10-K · filed 2026-03-25 | |||||||
| 2025-09-30 | 84.29M shares 10-Q · filed 2025-11-13 | |||||||
| 2025-06-30 | 141.75M shares 10-Q · filed 2026-08-04 | 34.15M shares 10-Q · filed 2025-08-12 | ||||||
| 2025-03-31 | 80.99M shares 10-Q · filed 2026-05-13 | 28.33M shares 10-Q · filed 2025-05-14 | ||||||
| 2024-12-31 | 82.60M shares 10-K · filed 2026-03-25 | 29.93M shares 10-K · filed 2025-03-19 | ||||||
| 2024-09-30 | 30.66M shares 10-Q · filed 2025-11-13 | |||||||
| 2024-06-30 | 28.19M shares 10-Q · filed 2025-08-12 | |||||||
| 2024-03-31 | 23.50M shares 10-Q · filed 2025-05-14 | |||||||
| 2023-12-31 | 23.02M shares 10-K · filed 2026-03-25 | |||||||
| 2023-09-30 | 22.91M shares 10-Q · filed 2024-11-14 | |||||||
| 2023-06-30 | 24.20M shares 10-Q · filed 2024-08-14 | |||||||
| 2023-03-31 | 18.82M shares 10-Q · filed 2024-05-14 | |||||||
| 2022-12-31 | 15.90M shares 10-K · filed 2025-03-19 | |||||||
| 2022-09-30 | 20.97M shares 10-Q · filed 2022-11-09 | 16.14M shares 10-Q · filed 2023-11-09 | 20.97M shares 10-Q · filed 2022-11-09 | |||||
| 2022-06-30 | 28.06M shares 10-Q · filed 2022-08-08 | 16.33M shares 10-Q · filed 2023-08-09 | 28.06M shares 10-Q · filed 2022-08-08 | |||||
| 2022-03-31 | 17.34M shares 10-Q · filed 2023-05-10 | 29.07M shares 10-Q · filed 2022-05-09 | ||||||
| 2021-12-31 | 12.85M shares 10-K · filed 2024-03-19 | 24.58M shares 10-K · filed 2022-03-01 | ||||||
| 2021-09-30 | 24.57M shares 10-Q · filed 2022-11-09 | 24.57M shares 10-Q · filed 2022-11-09 | ||||||
| 2021-06-30 | 25.07M shares 10-Q · filed 2022-08-08 | 25.07M shares 10-Q · filed 2022-08-08 | ||||||
| 2021-03-31 | 24.11M shares 10-Q · filed 2022-05-09 | |||||||
| 2020-12-31 | 13.12M shares 10-K · filed 2023-03-06 | 24.85M shares 10-K · filed 2021-03-01 | ||||||
| 2020-09-30 | 31.17M shares 10-Q · filed 2021-11-08 | 31.17M shares 10-Q · filed 2021-11-08 | ||||||
| 2020-06-30 | 38.16M shares 10-Q · filed 2021-08-09 | 38.16M shares 10-Q · filed 2021-08-09 | ||||||
| 2020-03-31 | 48.20M shares 10-Q · filed 2021-05-10 | |||||||
| 2019-12-31 | 32.26M shares 10-K · filed 2022-03-01 | |||||||
| 2019-09-30 | 32.83M shares 10-Q · filed 2020-11-09 | 32.83M shares 10-Q · filed 2020-11-09 | ||||||
| 2019-06-30 | 33.80M shares 10-Q · filed 2020-08-10 | 33.80M shares 10-Q · filed 2020-08-10 | ||||||
| 2019-03-31 | 36.15M shares 10-Q · filed 2020-05-11 | |||||||
| 2018-12-31 | 31.15M shares 10-K · filed 2021-03-01 | |||||||
| 2018-09-30 | 25.78M shares 10-Q · filed 2019-11-12 | 25.78M shares 10-Q · filed 2019-11-12 | ||||||
| 2018-06-30 | 12.53M shares 10-Q · filed 2019-08-09 | 12.53M shares 10-Q · filed 2019-08-09 | ||||||
| 2018-03-31 | 12.73M shares 10-Q · filed 2019-05-09 | |||||||
| 2017-12-31 | 11.52M shares 10-K · filed 2020-03-02 | |||||||
| 2017-09-30 | 12.78M shares 10-Q · filed 2018-11-08 | 12.78M shares 10-Q · filed 2018-11-08 | ||||||
| 2017-06-30 | 12.95M shares 10-Q · filed 2017-08-09 | 12.95M shares 10-Q · filed 2018-08-13 | ||||||
| 2017-03-31 | 12.63M shares 10-Q/A · filed 2018-08-13 | |||||||
| 2016-12-31 | 11.64M shares 10-K · filed 2019-03-01 | |||||||
| 2016-09-30 | 12.13M shares 10-Q · filed 2017-11-09 | 12.13M shares 10-Q · filed 2017-11-09 | ||||||
| 2016-06-30 | 11.36M shares 10-Q · filed 2017-08-09 | 11.36M shares 10-Q · filed 2017-08-09 | ||||||
| 2016-03-31 | 10.63M shares 10-Q · filed 2017-05-10 | |||||||
| 2015-12-31 | 11.24M shares 10-K · filed 2018-03-01 | |||||||
| 2015-09-30 | 10.85M shares 10-Q · filed 2016-11-09 | 10.85M shares 10-Q · filed 2016-11-09 | ||||||
| 2015-06-30 | 9.72M shares 10-Q · filed 2016-08-09 | 9.72M shares 10-Q · filed 2016-08-09 | ||||||
| 2015-03-31 | 4.72M shares 10-Q · filed 2016-05-10 | |||||||
| 2014-12-31 | 8.68M shares 10-K · filed 2017-03-01 | |||||||
| 2014-09-30 | 8.57M shares 10-Q · filed 2015-11-09 | |||||||
| 2014-06-30 | 9.00M shares 10-Q · filed 2015-08-10 | |||||||
| 2013-12-31 | 3.26M shares 10-K · filed 2016-02-29 | |||||||
| 2013-09-30 | 3.11M shares 10-Q · filed 2014-11-13 | |||||||
| 2013-06-30 | 78.77M shares 10-Q · filed 2014-08-14 | |||||||
| 2013-03-31 | 71.96M shares 10-Q · filed 2014-05-09 | |||||||
| 2012-12-31 | 67.34M shares 10-K · filed 2015-03-02 | |||||||
| 2012-09-30 | 64.72M shares 10-Q · filed 2013-11-07 | |||||||
| 2012-06-30 | 65.18M shares 10-Q/A · filed 2013-10-21 | |||||||
| 2011-12-31 | 59.61M shares 10-K · filed 2014-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NewAmsterdam Pharma Co N.V. (NAMS) | $2.719B | -15.37 | |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Dyne Therapeutics, Inc. (DYN) | United States | $3.084B | -7.09 |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |